These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 26489624)
1. Angiogenic factors are associated with development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Nie DM; Wu QL; Zhu XX; Zhang R; Zheng P; Fang J; You Y; Zhong ZD; Xia LH; Hong M J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):694-699. PubMed ID: 26489624 [TBL] [Abstract][Full Text] [Related]
2. Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: a clinical analysis. Wu Q; Chen H; Fang J; Xie W; Hong M; Xia L Leuk Res; 2012 Mar; 36(3):275-80. PubMed ID: 21917312 [TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia. Zhang Y; Zheng H; Ren J; Luo X; Zheng Z; Zheng J; Zheng X; Chen Y; Chen Z; Hu J; Yang T Hematol Oncol; 2021 Aug; 39(3):380-389. PubMed ID: 33848027 [TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985 [TBL] [Abstract][Full Text] [Related]
5. Simvastatin ameliorates graft-vs-host disease by regulating angiopoietin-1 and angiopoietin-2 in a murine model. Zheng P; Wu QL; Li BB; Chen P; Nie DM; Zhang R; Fang J; Xia LH; Hong M Leuk Res; 2017 Apr; 55():49-54. PubMed ID: 28122283 [TBL] [Abstract][Full Text] [Related]
7. Frequency analysis of TRBV subfamily sjTRECs to characterize T-cell reconstitution in acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Wu X; Zhu K; Du X; Chen S; Yang L; Wu J; Liu Q; Li Y J Hematol Oncol; 2011 Apr; 4():19. PubMed ID: 21513557 [TBL] [Abstract][Full Text] [Related]
8. Identification of Heme Oxygenase-1 as a Novel Predictor of Hematopoietic Stem Cell Transplantation Outcomes in Acute Leukemia. Lu Y; Wu D; Wang J; Li Y; Ma D; Chai X; Kang Q Cell Physiol Biochem; 2016; 39(4):1495-502. PubMed ID: 27606430 [TBL] [Abstract][Full Text] [Related]
9. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia. Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612 [TBL] [Abstract][Full Text] [Related]
10. Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation. Yu J; Parasuraman S; Shah A; Weisdorf D Curr Med Res Opin; 2019 Jun; 35(6):983-988. PubMed ID: 30461314 [TBL] [Abstract][Full Text] [Related]
11. [Clinical study of anti-human T cell porcine immunoglobulin with recombinant human tumor necrosis factor-α receptor II: IgG Fc in the treatment of 35 cases of grade III/IV acute graft-versus-host disease after allo-HSCT]. Liu DY; Yan S; Ma DD; Zhang C; Fu KB; Liu XM; Liu XH; Wang Y; Li XQ; Zhang JQ; Xiu YY; Peng XJ Zhonghua Xue Ye Xue Za Zhi; 2020 Sep; 41(9):743-748. PubMed ID: 33113606 [No Abstract] [Full Text] [Related]
12. [Clinical significance of TNF-alpha, IL-1beta and IFN-gamma levels at early phase after allogeneic hematopoietic stem cell transplantation]. Gao HL; Sun AN; Han Y; Zhang W; Hu XH; Wu DP; Ruan CG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1321-5. PubMed ID: 19840475 [TBL] [Abstract][Full Text] [Related]
13. Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802. Holtan SG; Verneris MR; Schultz KR; Newell LF; Meyers G; He F; DeFor TE; Vercellotti GM; Slungaard A; MacMillan ML; Cooley SA; Blazar BR; Panoskaltsis-Mortari A; Weisdorf DJ Biol Blood Marrow Transplant; 2015 Jun; 21(6):1029-36. PubMed ID: 25759146 [TBL] [Abstract][Full Text] [Related]
14. Icariin protects against acute graft-versus-host disease while preserving graft-versus-leukemia activity after allogeneic hematopoietic stem cell transplantation. Su L; Wei ZF; Pi CC; Qin TX; Song F; Zhang YW; Gao SJ Phytomedicine; 2024 Sep; 132():155901. PubMed ID: 39067193 [TBL] [Abstract][Full Text] [Related]
15. [Comparative analysis between autologous and allogeneic hematopoietic stem cell transplantation in 114 adult patients with acute lymphoblastic leukemia in long-term follow-up]. Bao YS; Jiang EL; Wang M; Wang H; Huang Y; Wei JL; Yang DL; Feng SZ; Qiu LG; Han MZ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1325-9. PubMed ID: 19099637 [TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation. Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744 [TBL] [Abstract][Full Text] [Related]
17. [Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease]. Sun AN; Wu DP; Wang Y; Qiu HY; Jin ZM; Miao M; Tang XW; Fu ZZ; Ma X; Han Y; He GS; Chen SN; Xue SL; Zhao Y Ai Zheng; 2006 Aug; 25(8):1019-22. PubMed ID: 16965686 [TBL] [Abstract][Full Text] [Related]
18. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease. Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656 [TBL] [Abstract][Full Text] [Related]
19. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578 [TBL] [Abstract][Full Text] [Related]
20. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation. Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]